awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43078724-5315F465-86B3-4E73-9C01-471CD7C825F5
Q43078724-5315F465-86B3-4E73-9C01-471CD7C825F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43078724-5315F465-86B3-4E73-9C01-471CD7C825F5
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial.
P1476
Q43078724-5315F465-86B3-4E73-9C01-471CD7C825F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43078724-5315F465-86B3-4E73-9C01-471CD7C825F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
145296dfe6957900407d0693ddd59a0135e741f9
P1476
Enoxaparin 0.3 mg/kg IV supple
......
alysis from the SYNERGY trial.
@en